Learning more about the mTOR complex and how it works is a stepping stone for others who might look for cancer therapies or ways to help treat diabetes and other diseases. In the world of biology, ...
Fig 1. PI3K/AKT/mTOR signaling pathway showing interacting activation and regulatory feedback loops. Adapted from Hoeffer and Klann. 35 Mammalian target of rapamycin (mTOR) is a serine-threonine ...
Sirolimus may be an effective treatment for patients with persistent cutaneous sarcoidosis. In a small clinical trial, 7 of 10 patients treated with sirolimus via oral solution had improvements in ...
Findings from a prospective, randomized trial indicate that wound healing problems observed in early studies of high exposure to mTOR inhibitors can be prevented by using a dual regimen of everolimus ...
Most patients with a nonmalignant form of kidney tumor had significant tumor shrinkage with the mammalian target of rapamycin (mTOR) inhibitor everolimus (Afinitor), a small multicenter clinical trial ...
Network map of 29 authors with frequency greater than five. Nodes represent authors, and the larger the node, the higher the number of papers. The lines represent collaborations with other authors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results